ORIC Pharmaceuticals, Inc. (ORIC) has a consensus analyst rating of Buy, based on 10 analysts covering the stock. Of those, 10 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for ORIC is $21.75, representing a +106.6% upside from the current price of $10.53. Price targets range from a low of $15.00 to a high of $25.00.
